Daiichi Sankyo, Inc.
Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Job Summary:
This is a remote, field-based role that can be done from anywhere in the US South Central.
As member of US Medical, Field Medical Affairs team, the Principal Health Outcomes Liaison/Sr. Health Outcomes Liaison provides scientific and health economics/outcomes research support for DSI initiatives and engages in dissemination of DSI product/portfolio total value proposition (TVP), upon request to customers in various US healthcare segments, with a predominant payor focus. In addition, the Health Outcomes Liaison will have demonstrated leadership commensurate with a senior level position at Daiichi Sankyo (DSI) demonstrated by innovation and ability to anticipate trends and capitalize on opportunities.
Responsibilities:
Anticipates and capitalizes on opportunities with existing and new HOL customers by conducting the following:
.
Enhances relationships with appropriate internal stakeholders through the anticipation of trends and recognition of strategic opportunities.
Provides assistance to leadership in the development and implementation of the FMA department strategy in alignment with Medical, Managed Markets and Brand strategies, and by providing input/participating in Medical Affairs and FMA strategic planning processes.
Develops the ability to strategically establish, gain support for, and lead national level projects/initiatives by providing leadership through alignment across DSI functions.
Complete administrative duties, including monthly expense reporting and field activity reporting
Develops ability to fully represent FMA Leadership at DSI meetings, functions, events.
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education/Experience:
PharmD, M.D., or Ph.D in a health sciences related field required; Master’s in pharmaco-epidemiology, epidemiology, or health economics preferred.
Principal Health Outcomes Liaison must have: 4 or more years of experience including medical & scientific affairs, clinical practice, research, academic or US managed markets required with a minimum of 4 years in the pharmaceutical industry preferred. Additional expertise must include 1-year of experience as a Sr. Health Outcomes Liaison or related experience required.
Senior Health Outcomes Liaison must have: 4 or more years of experience including medical & scientific affairs, clinical practice, research, academic or US managed markets required with a minimum of 3 years in the pharmaceutical industry preferred. Additional expertise must include 1-year of experience as a Health Outcomes Liaison or related experience required.
Previous experience in oncology, pharmaco-economics, health outcomes research, disease management principles and tools, and Real-World Evidence (RWE) is highly desirable.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.